Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Obstetrical safety indicators for preventing hospital harms: a scoping review protocol

View ORCID ProfileA Conway, View ORCID ProfileJ Reszel, View ORCID ProfileMC Walker, View ORCID ProfileJM Grimshaw, SI Dunn
doi: https://doi.org/10.1101/19012153
A Conway
1Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada
2Better Outcomes Registry & Network (BORN), Children’s Hospital of Eastern Ontario - Ottawa Children’s Treatment Centre (CHEO-OCTC), Ottawa, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A Conway
  • For correspondence: aislinnconway@gmail.com
J Reszel
2Better Outcomes Registry & Network (BORN), Children’s Hospital of Eastern Ontario - Ottawa Children’s Treatment Centre (CHEO-OCTC), Ottawa, Ontario, Canada
3Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J Reszel
MC Walker
2Better Outcomes Registry & Network (BORN), Children’s Hospital of Eastern Ontario - Ottawa Children’s Treatment Centre (CHEO-OCTC), Ottawa, Ontario, Canada
4Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
5School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
8Obstetrics, Maternal and Newborn Investigations (OMNI) Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
9Department of Obstetrics, Gynecology and Newborn Care, The Ottawa Hospital, Ottawa, Ontario, Canada
10Department of Obstetrics and Gynecology, The University of Ottawa, Ottawa, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for MC Walker
JM Grimshaw
4Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
5School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
6Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for JM Grimshaw
SI Dunn
1Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada
2Better Outcomes Registry & Network (BORN), Children’s Hospital of Eastern Ontario - Ottawa Children’s Treatment Centre (CHEO-OCTC), Ottawa, Ontario, Canada
7School of Nursing, University of Ottawa, Ottawa, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Optimizing the safety of obstetric patient care is a primary concern for many hospitals. Identifying performance indicators that measure aspects of patient care processes related to preventable harms can present opportunities to improve health systems.

In this paper, we present our protocol for a scoping review to identify performance indicators for obstetric safety. We aim to identify a comprehensive list of obstetric safety indicators which may help reduce the number of preventable patient harms, to summarize the data and to synthesize the results.

Methods and analysis We will use the methodological framework described by Arksey and O’ Malley and further expanded by Levac. We will search multiple electronic databases such as Medline, Embase, CINAHL and the Cochrane Library as well as websites from professional bodies and other organisations, using an iterative search strategy. We will include indicators that relate to preventable harms in the process of obstetric care.

Two reviewers will independently screen titles and abstracts of search results to determine eligibility for inclusion. For records where eligibility is not clear, the reviewers will screen the full text version. If reviewers’ decisions regarding eligibility differ, a third reviewer will review the full text record. Two reviewers will independently extract data from records that meet our inclusion criteria using a standardized data collection form. We will narratively describe quantitative data, such as the frequency with which indicators are identified, and conduct a thematic analysis of the qualitative data. We will compile a comprehensive list of patient safety indicators identified during our scoping review and organise them according to concepts that best suit the data such as the Donabedian model or the Hospital Harm Framework. We will discuss the implications of the indicators for future research, clinical practice and policy making.

We will report the conduct of the review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA ScR) Checklist.

Ethics and Dissemination The sources of information included in this scoping review will be available to the public. Therefore, ethical review for this research is not warranted. We will disseminate our research results using multiple modes of delivery such as a peer-reviewed publication, conference presentations and stakeholder communications.

Strengths and limitations of this study

  1. We will use systematic methods to conduct and report this scoping review based on established methods introduced by Arksey and O’ Malley and further developed by Levac.

  2. We will report the conduct of the review using guidance from the PRISMA Extension for Scoping Reviews (PRISMA-ScR).

  3. We will limit the focus of this review to patient safety indicators from English language resources aimed at health system processes in developed countries.

  4. We will not assess the risk of bias or certainty of the evidence in the included records because this is a scoping review to identify potential obstetrical safety indicators.

  5. After the scoping review, we will present the identified indicators to key informants in a consensus process to create a shortlist that may not be suitable for inclusion in a future obstetrical safety dashboard for BORN (Better Outcomes Registry and Network) Ontario. BORN collects and safeguards data, and shares information to improve the delivery of maternal, neonatal and child healthcare across the province.

Introduction

An aim of healthcare delivery is to avoid preventable harm to patients. However, human limitations and the complex nature of health care systems are contributing factors that make errors an expected phenomenon (1). A systematic review by Nabhan and colleagues found that the most frequently used definition of preventable harms is “presence of an identifiable, modifiable cause of harm” (2). Preventable harms that occur during hospital stays are also known as hospital harms, patient safety incidents, hospital adverse events or hospital errors. The Canadian Institute for Health Information (CIHI) defines hospital harms as the “rate of acute care hospitalizations with at least one occurrence of unintended harm during a hospital stay that could have been potentially prevented by implementing known evidence-informed practices” (3).

In 2000, the Institute of Medicine in the United States published a ground-breaking report To Err is Human: Building a Safer Health System (4) which raised awareness around errors in healthcare processes and their negative impact on patient morbidity and mortality. In 2004, the results of the Canadian Adverse Events Study showed that according to the sample of 3745 non-psychiatric, non-obstetric adult patient charts reviewed, the rate of preventable adverse events was 2.8% (95% confidence interval [CI], weighted, 2.0 – 3.6) and the mortality rate from preventable adverse events was 0.66% (95% CI, weighted, 0.37%–0.95%) (5). Since then, the Canadian Patient Safety Institute (CPSI) reported that patient harm is Canada’s third highest cause of death. Preventable harms occur in one out of every 18 hospital visits and resulting treatments costs CAD$2.75 billion annually (6). Regarding the field of obstetrics, the most recently published hospital harm results from the Canadian Institute for Health Information (CIHI) and the Canadian Patient Safety Institute (CPSI), (7) during the fiscal year 2017 – 2018, reported 5566 incidences of obstetric trauma caused by health care or medication-associated conditions and 4242 incidences caused by procedure-associated conditions. They also reported that during the same period, 670 incidences of obstetric hemorrhage were caused by health care or medication associated conditions and 960 incidences were caused by procedure associated-conditions. In addition, 855 birth trauma incidences were caused by health care or medication-associated conditions and 1417 incidences were caused by procedure-associated conditions.

Certain harms require exploration of each patient case to assess whether the harm is potentially preventable, and others are more obviously preventable, such as fatal medication doses (8) or wrong-site surgeries. The Hospital Harm Framework classifies harms into 4 categories: health care/medication-associated conditions; health care associated infections; patient accidents; and procedure-associated conditions (9).

Several studies have shown strategies that have successfully reduced preventable patient harm. Existing research has shown that making patient safety central to the delivery of care can lead to system-level improvements. In the United States, Pettker and colleagues implemented a comprehensive obstetric patient safety program which led to reductions in adverse outcomes and litigation cases, and improvements in staff perceptions of safety and improvements in the safety climate, (10–12). Also in the United States, the California Maternal Quality Care Collaborative [CMQCC] California has identified a correlation between the work of perinatal quality collaboratives (PQCs) and a 50% reduction in maternal mortality rates in the state of California (13).

Audit and feedback interventions may help to prevent patient harm. The Institute for Healthcare Improvement (IHI) Framework for Safe, Reliable and Effective Care identifies processes of improvement and measurement as a part of the health care learning system (14). In the UK, an ethnographic study of a maternity unit with an excellent record for patient safety found that staff partly attributed its success to a maternity dashboard which facilitated audit and feedback (15). The Better Outcomes Registry & Network (BORN Ontario) developed a dashboard of six key clinical performance indicators to measure data relating to the quality of maternal and newborn patient care in Ontario, Canada (16–18). In a pilot study, a quality improvement project focusing on one of the indicators identified by BORN, led to a welcome and significant reduction in the rate of elective repeat caesarean sections (ECRS) in low risk women at less than 39 weeks’ gestation (19). In an interrupted time series study that evaluated post-implementation effectiveness of the maternal newborn dashboard, the researchers found that it led to improvements in four of the six key indicators (20). A systematic review by Ivers and colleagues (21) found that audit and feedback can lead to small improvements in the practice of care delivery by health care professionals. In a rapid review, Anthony and colleagues found that audit and feedback in combination with other obstetrical safety initiatives may reduce maternal and neonatal morbidity and mortality (22).

It is necessary to identify patient safety indicators to ensure the effectiveness of future audit and feedback strategies. Hearnshaw and colleagues have highlighted the need for useful audit review criteria that are developed or selected using systematic methods (23,24). However, in the field of obstetrics, it is currently unclear which indicators relate to, or have the potential to improve obstetric safety. In this scoping review, we want to contribute to the improvement of obstetric patient safety by identifying indicators as the starting point of an approach to harm reduction.

The term indicator is generally understood to mean a measure that provides information on health service delivery across organisations which enables tracking and comparison of performance over time. In a paper first published in 1966, Donebedian identified three types of measures of quality which can be used to evaluate the process of care at the patient-healthcare provider level; outcome measures; process measures and structure measures (25). A fourth type, balancing measures, relate to positive or negative phenomenon which happen as an unintended consequence of a change (14).

Many desirable criteria for measuring the quality of care delivered by a health system have been proposed in the literature. Kessner and colleagues (26) suggested using tracers which are a set of specific health conditions or activities. They identified the following criteria for tracers: having the potential to be positively impacted by health care activities, clearly definable and easily diagnosable, have a level of prevalence that leads to data collection adequate for statistical analysis, having a demonstrable potential to improve health conditions, relate to processes involving prevention, diagnosis, treatment or rehabilitation, and contextual influences should be understood. Janakariaman and Ecker listed their ideal criteria for measures as: easily definable and observable; important to patients and health care professionals; identifies areas where improvements are needed and uses accessible data (27).

A systematic review by Saturno-Hernández and colleagues found that despite the existence of a large number of indicators for monitoring obstetric care, they were lacking in scientific rigor and many are not suitable for implementation (28). They used the following desirable criteria for indicators: presenting a full description, clearly based on explicit evidence, reliable, and feasible (confirmed by pilot testing).

Although it is likely that indicators have the potential to improve patient safety there are no consistent standards for measuring obstetric patient safety. When deciding on indicators it is extremely important to understand what you want to measure and how it can be measured effectively. In order to use obstetric safety indicators as part of a harm reduction strategy they should resonate with health care professionals.

Quality and safety indicators are closely linked and sometimes used interchangeably. However, safety indicators are a sub-type of quality indicators. For this review, we will use the definition of patient safety indicators used by Kristensen and colleagues i.e. measures that directly or indirectly monitor preventable hospital harms (29). For these indicators it is important to map indicators to goals which are actionable. In the field of obstetric patient safety, there is a need to identify indicators which measure the aspects of care that relate to preventable harms caused by medical errors. This can be challenging because it is not always clear which indicators should be used and there are variations in practice and outcomes across hospitals, regions etc.

It is important to note that some safety indicators may be judged as avoidable depending on the patient case. Therefore, we will focus on obstetric safety indicators that relate to the prevention of harms that are at least partly potentially avoidable to patients.

The aim of our review will be to scope the body of relevant literature (30) to identify a comprehensive list of potential obstetric safety indicators which can help reduce preventable patient harms. The objectives of the scoping review are to search for and identify records discussing indicators that can optimize obstetrical safety, to summarize the data and to synthesize the results. This scoping review is being undertaken to inform which indicators will be included in a patient safety dashboard from BORN Ontario.

Methods and analysis

We will undertake a scoping review to systematically map the available literature on performance indicators relevant to the reduction of preventable harms within the purview of obstetric safety. We will use the PRISMA extension for scoping reviews PRISMA ScR Checklist (31) to guide the reporting of the scoping review. We will use the scoping study framework introduced by Arksey and O’ Malley (32) and the recommendations later developed by Levac (33) to guide our methods. We will follow all six suggested stages as described below.

Stage 1: Identifying the research question

Through consultation with the author team we defined the concepts, target population and type of indicators of interest, and iteratively developed the main research question for the scoping review. We ensured that it aligned with the purpose and scope of the review and the expected outcome (a comprehensive list of relevant indicators).

This question is: According to the available literature, what are the obstetrical safety indicators related to processes of care for low risk births that aim to reduce preventable hospital harms?

For the purposes of this review, we will use the Southern Ontario Obstetrical Network (SOON) definition of a low-risk birth target population namely, nulliparous pregnant individuals, singleton gestation with cephalic presentation, who deliver at 37 weeks of gestation or more (34). SOON has also specified exclusion criteria shown in the table in Appendix 2. The term ‘fetal anomalies’ featured in the SOON definition is an umbrella term for multiple anomalies. Therefore, we will use the list of major sentinel congenital anomalies (see Appendix 3) that was developed in 2017 by BORN Ontario and OCAC (Ontario Congenital Anomalies Committee) as an additional tool during screening.

Stage 2: Identifying relevant studies

The search strategy will be drafted by one of the authors who has trained as an information specialist (AC) and developed iteratively based on consultation with the author team and at least one other library and information professional. We will aim to be as comprehensive as possible while considering resource constraints (such as time) to avoid large volumes of search results. We will search electronic databases such as Medline (Ovid), Embase Classic + Embase 1947 to 2019 (Ovid), CINAHL (EBSCO), the Cochrane Library via www.cochranelibrary.com. We will search for grey literature resources such as those identified in the Canadian Agency for Drugs and Technologies in Health (CADTH) grey literature checklist Grey Matters: a practical tool for searching health-related grey literature (35). We will also search relevant websites of professional bodies or organisations such as the Society of Obstetricians and Gynaecologists of Canada (SOGC)(36), Royal College of Obstetricians and Gynaecologists (RCOG)(37), Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) (38) and American College of Obstetricians and Gynecologists (ACOG) (39) etc. We will contact individuals or groups to source additional material if deemed appropriate.

We will use both thesauri terms (such as MeSH, Emtree and CINAHL headings) and free text terms as well as Boolean operators and field limiters (where appropriate), to build our search. We will report our conduct of the search including information such as: each database or source of information; dates of the searches; applied limits or filters; the number of records found (for each database or source of information) and search terms from at least one electronic database. We will undertake reference searching and citation searching for records which meet our inclusion criteria.

See Appendix 1 for our currently proposed search strategy for Medline which may be further developed before it is implemented. It will be tailored according to the functionality of each database or other resource we search.

Stage 3: Selecting studies

Two reviewers will undertake a test of interrater reliability to increase the likelihood of reliable screening. We will select 50 records and screen them for inclusion. We will calculate Cohen’s kappa (40). We may revise the inclusion and exclusion criteria if indicated. When we have achieved a 0.80 or higher level of agreement between raters, we will independently conduct three phases of screening. Firstly, we will screen the titles and abstracts of records that are not randomized trials to determine eligibility for inclusion against the agreed inclusion and exclusion criteria using screening software (Covidence). Secondly, we will screen 30 randomised trials to see if they identify additional indicators. If this step is not useful, we will not screen the remaining randomised trials. Thirdly, two reviewers will independently screen the full-text records for which it was not clear whether they met inclusion criteria in the previous screening phase. If there is disagreement regarding the inclusion of a record(s), another reviewer will assess the full text. We will undertake interrater reliability testing after every 1,000 records screened.

Records will be selected using the following inclusion criteria:

  • one or more indicator is proposed or in use to prevent harm and improve obstetric safety

  • specifies or includes a low risk birth population

  • in-hospital settings

  • care during the period from admission to discharge from hospital following birth

  • indicators that can be improved or are controllable

  • feature a level of measurability/auditability

We will include any type of primary study and most other record types discussing indicators such as reports, guidance documents and discussion papers, with the exception of conference papers. We will not exclude sources based on the year they were made available or published, or on their publication status (published or unpublished). We will only include English language records due to resource restrictions for translation services. We will exclude records focusing on indicators specifically designed for use within underdeveloped or developing world settings because our indicators should be applicable to a developed country (Canada).

We will present an adapted PRISMA flow diagram (41) to document the number of records identified, screened, assessed for eligibility, and included or excluded. We will document the main reasons why records were excluded.

Stage 4: Charting the data

We will identify variables that are relevant and develop a standardized data collection form (15). Two reviewers will independently carry out data extraction for each included record. Initially, we will independently extract data from five randomly-selected, included records and compare the extracted data for consistency. The form may be iteratively developed throughout the charting process. Data items will include:

  • indicator source (bibliographic information)

  • study design and/or record format

  • country of origin

  • type of indicator (outcome/process/structure/balancing)

  • indicator name

  • indicator definition

  • numerator

  • denominator

  • measurement properties (tools, instruments etc.)

  • the population that is targeted by the indicator; maternal, fetal or infant following birth (or a combination)

  • the timeframe covered by the indicator; admission for birth including care during labour, during birth, during the postpartum period prior to discharge from hospital

  • category of hospital harm being addressed

  • whether indicator relates to a desirable or undesirable event

  • evidence-based indicator (yes/no/unclear)

Stage 5: Collating, summarizing and reporting results

As recommended by Levac, we will divide this final stage into three parts: analysis of data; reporting of results and discussion of the implications of the results for research, practice and policy (33).

  1. We will produce descriptive numerical summaries through analysis of the quantitative data, such as the frequency with which indicators are identified. The qualitative data will be uploaded to NVivo software and thematic analysis will be conducted.

  2. We will report our results by compiling a comprehensive list of patient safety indicators identified during our scoping review and organizing them according to concepts that best suit the data such as the Donabedian model or categories within the Hospital Harm Framework.

  3. We will further explore the implications of the indicators for further research, on clinical practice within obstetric units and how policy analysts or policy-makers may find the results useful.

Stage 6: Consultation

This stage is presented as optional by Arksey and O’ Malley (32) and Levac and colleagues argue that it should be considered a necessary element of the methodological framework. Data from our scoping review will be fed into a future consensus process. This scoping review is the first in a multi-step approach to inform the development of a core set of indicators. It is unclear which measures will be considered important to stakeholders so the results of the research will be disseminated to a panel of experts in a consensus process. They will prioritize indicators and we will produce a shortlist with the potential to inform the development of a future obstetrical safety dashboard in the Ontarian health system. As an electronic audit and feedback system, the dashboard could be used to capture, monitor and report surveillance data entered by health care professionals, and aim to contribute to improvements in obstetric safety.

Data Availability

The data will be made publicly available on the Open Science Framework or by request at: aislinnconway@gmail.com

https://osf.io

Ethics and Dissemination

This scoping review will not require ethical approval because included sources are or can be made available to the public (42).

This research will be disseminated with the intention of reaching a wide audience through the use of multiple modes of delivery such as stakeholder engagement, publication(s) in a peer-reviewed journal and conference paper(s).

Authors’ contributions

In consultation with all authors, AC wrote the first draft which SID and JR reviewed. JMG and MCW reviewed a second draft. All authors contributed to the planning and writing of this protocol and approved submission of the final manuscript to the publishing journal.

Funding

AC is the recipient of a Health Systems Impact Fellowship co-funded by the Canadian Institutes of Health Research Institute of Health Services and Policy Research (CIHR-IHSPR) and the Children’s Hospital of Eastern Ontario (CHEO) Research Institute.

Competing interests

The authors declare that there are no competing interests.

Appendix

View this table:
  • View inline
  • View popup
Appendix 1:

Search strategy for Medline (Ovid)

View this table:
  • View inline
  • View popup
  • Download powerpoint
Appendix 2:

Southern Ontario Obstetrical Network (SOON) low-risk birth definition.

View this table:
  • View inline
  • View popup
Appendix 3:

Major sentinel congenital anomalies list

References

  1. 1.↵
    Pettker CM, Grobman WA. Obstetric Safety and Quality. Obstet Gynecol. 2015;126(1):196–206.
    OpenUrlPubMed
  2. 2.↵
    Nabhan M, Elraiyah T, Brown DR, Dilling J, LeBlanc A, Montori VM, et al. What is preventable harm in healthcare? A systematic review of definitions. BMC Health Serv Res. 2012;12:128.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Canadian Institute for Health Information (CIHI). Indicator Library - Hospital Harm [Internet]. Available from: http://indicatorlibrary.cihi.ca/pages/viewpage.action?pageId=10453027
  4. 4.↵
    Institute of Medicine. To Err is Human: Building a Safer Health System. National Academies Press; 2000. 443 p.
  5. 5.↵
    Baker GR, Norton PG, Flintoff V, Blais R, Brown A, Cox J, et al. The Canadian Adverse Events Study: The incidence of adverse events among hospital patients in Canada. Can Med Assoc J. 2004;170(11):1678–86.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Institute CPS. Awareness of the Patient Safety Crisis in Canada [Internet]. [cited 2019 May 7]. Available from: https://www.patientsafetyinstitute.ca/en/toolsresources/Awareness-of-the-Patient-Safety-Crisis-in-Canada/Pages/Awareness-of-the-Patient-Safety-Crisis-in-Canada-2019-04-23.aspx
  7. 7.↵
    Canadian Institute for Health Information (CIHI). Hospital harm results, 2014–2015 to 2017–2018 [Internet]. 2019 [cited 2019 May 7]. Available from: Canadian Institute for Health Information, hospital harm results www.cihi.ca/sites/default/files/document/hospital-harm-data-tables-april2019-en-web.xlsx
  8. 8.↵
    van Doormaal JE, van den Bemt PMLA, Mol PGM, Zaal RJ, Egberts ACG, Haaijer-Ruskamp FM, et al. Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Qual Saf Heal Care. 2009 Feb 1;18(1):22 LP–27.
    OpenUrl
  9. 9.↵
    Canadian Institute for Health Information (CIHI). Hospital Harm Indicator: General Methodology Notes [Internet]. 2019. Available from: http://indicatorlibrary.cihi.ca/display/HSPIL/Hospital+Harm?_ga=2.120753928.1423793767.1563286199-954873353.1555606353&preview=/10453027/15564910/HospitalHarmIndicatorGeneralMethodologyNotes.pdf
  10. 10.↵
    Pettker CM, Thung SF, Norwitz ER, Buhimschi CS, Raab CA, Copel JA, et al. Impact of a comprehensive patient safety strategy on obstetric adverse events. Am J Obstet Gynecol. 2009;200(5):492.e1-492.e8.
    OpenUrlCrossRefPubMed
  11. 11.
    Pettker CM, Buhimschi CS, Lockwood CJ, Thung SF, Illuzzi JL, Funai EF, et al. A comprehensive obstetric patient safety program reduces liability claims and payments. Am J Obstet Gynecol. 2014;211(4):319–25.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Pettker CM, Thung SF, Raab CA, Donohue KP, Copel JA, Lockwood CJ, et al. A comprehensive obstetrics patient safety program improves safety climate and culture. Am J Obstet Gynecol. 2011 Mar;204(3):216.e1-216.e6.
    OpenUrlCrossRefPubMed
  13. 13.↵
    Main EK. Reducing Maternal Mortality and Severe Maternal Morbidity. Clin Obstet Gynecol. 2018;61(2):319–31.
    OpenUrl
  14. 14.↵
    Frankel A, Haraden C, Federico F, et al. A Framework for Safe, Reliable, and Effective Care. White Pap Cambridge, MA Inst Healthc Improv Safe Reliab Healthc. 2017;1–32.
  15. 15.↵
    Liberati EG, Tarrant C, Willars J, Draycott T, Winter C, Chew S, et al. How to be a very safe maternity unit: An ethnographic study. Soc Sci Med. 2019;223(July 2018):64–72.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Sprague AE, Dunn SI, Fell DB, Harrold J, Walker MC S. K, et al. Measuring Quality in Maternal-Newborn Care: Developing a Clinical Dashboard. J Obstet Gynaecol Canada [Internet]. 2013;35(1):29–38. Available from: http://www.journals.elsevier.com/journal-of-obstetrics-and-gynaecology-canada/ %0A http://www.journals.elsevier.com/journal-of-obstetrics-and-gynaecology-canada/ %0A http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=20160444985 %0A http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=medl&NEWS=N&AN=23343794 %0Ahtt
    OpenUrl
  17. 17.
    Dunn S, Sprague AE, Grimshaw JM, Graham ID, Taljaard M, Fell D, et al. A mixed methods evaluation of the maternal-newborn dashboard in Ontario: dashboard attributes, contextual factors, and facilitators and barriers to use: a study protocol. Implement Sci [Internet]. 2015 Dec 4;11(1):59. Available from: http://implementationscience.biomedcentral.com/articles/10.1186/s13012-016-0427-1
    OpenUrl
  18. 18.↵
    Reszel J, Dunn S, Sprague A, Graham I, Grimshaw J, Peterson W, et al. Use of a maternal newborn audit and feedback system in Ontario: A collective case study. BMJ Qual Saf.
  19. 19.↵
    Dunn S, Sprague AE, Fell DB, Dy J, Harrold J, Lamontagne B, et al. The use of a quality indicator to reduce ERCS for low-risk women before 39 weeks gestation. 2013. p. 306–16.
  20. 20.↵
    Weiss D, Dunn SI, Sprague AE, Fell DB, Grimshaw JM, Darling E, et al. Effect of a population-level performance dashboard intervention on maternal-newborn outcomes: An interrupted time series study. BMJ Qual Saf. 2018;27(6):425–36.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    Ivers N, Jamtvedt G, Flottorp S, Young J, Odgaard-Jensen J, French S, et al. Audit and feedback : effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;(6):1–217.
  22. 22.↵
    Antony J, Zarin W, Pham B, Nincic V, Cardoso R, Ivory JD, et al. Patient safety initiatives in obstetrics: a rapid review. BMJ Open. 2018 Jul 6;8(7):e020170.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Hearnshaw H, Harker R, Cheater F, Baker R, Grimshaw G. A study of the methods used to select review criteria for clinical audit. Health Technol Assess (Rockv). 2002;6(1):1–87.
    OpenUrlCrossRef
  24. 24.↵
    Hearnshaw HM. Are audits wasting resources by measuring the wrong things? A survey of methods used to select audit review criteria. Qual Saf Heal Care. 2003;12(1):24–8.
    OpenUrl
  25. 25.↵
    Donabedian A. Evaluating the quality of medical care. Reprinted 1966 article. Milbank Q. 2005;83(4):691–729.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Kessner DM, Kalk CE, Singer J. Assessing health quality - the case for tracers. NEJM New Engl J Med. 1973;288:189–94.
    OpenUrl
  27. 27.↵
    Janakiraman V, Ecker J. Quality in obstetric care: Measuring what matters. Obstet Gynecol. 2010;116(3):728–32.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    Saturno-Hernández PJ, Martínez-Nicolás I, Moreno-Zegbe E, Fernández-Elorriaga M, Poblano-Verástegui O. Indicators for monitoring maternal and neonatal quality care: A systematic review. BMC Pregnancy Childbirth. 2019;19(1):1–11.
    OpenUrl
  29. 29.↵
    Kristensen S, Mainz J, Bartels. Establishing a Set of Patient Safety Indicators - Safety Improvement for Patients in Europe [Internet]. 2007. Available from: http://www.zdravstvo-kvaliteta.org/attachments/article/18/Patient_safety_indicator_development.pdf
  30. 30.↵
    Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):1–7.
    OpenUrl
  31. 31.↵
    Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467–73.
    OpenUrlCrossRefPubMed
  32. 32.↵
    Arksey H, O’Malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19–32.
    OpenUrl
  33. 33.↵
    Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(69).
  34. 34.↵
    Provincial Council for Maternal and Child Health. Safe Administration of Oxytocin Standardizing practice to promote safe induction and augmentation of labour [Internet]. 2019. Available from: https://www.pcmch.on.ca/wp-content/uploads/2019/09/PCMCH-Safe-Administration-of-Oxytocin.pdf
  35. 35.↵
    Canadian Agency for Drugs and Technologies in Health. Grey Matters: a practical tool for searching health-related grey literature [Internet]. 2019. Available from: https://www.cadth.ca/resources/finding-evidence/grey-matters
  36. 36.↵
    The Society of Obstetricians and Gynaecologists of Canada. Society of Obstetricians and Gynaecologists of Canada (SOGC) [Internet]. Available from: https://www.sogc.org
  37. 37.↵
    Royal College of Obstetricians and Gynaecologists. Royal College of Obstetricians and Gynaecologists (RCOG) [Internet]. 2019 [cited 2019 May 7]. Available from: https://www.rcog.org.uk/
  38. 38.↵
    The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Royal Australian and New Zealand College of Obstetricians and Gynaecologists [Internet]. 2019. Available from: https://ranzcog.edu.au
  39. 39.↵
    American College of Obstetricians and Gynecologists. American College of Obstetricians and Gynecologists. 2019 Available from: https://www.acog.org
  40. 40.↵
    Mchugh ML. Interrater reliability : the kappa statistic. Biochem Medica. 2012;22(3):276–82.
    OpenUrl
  41. 41.↵
    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009 Jul 21;6(7):e1000097.
    OpenUrlCrossRefPubMed
  42. 42.↵
    Interagency Advisory Panel on Research Ethics (PRE). Tri-Council Policy Statement: Ethical Conduct of Research Involving Humans, 2nd edition (TCPS 2). Article 2.2 [Internet]. 2014. Available from: http://www.pre.ethics.gc.ca/eng/policy-politique/initiatives/tcps2-eptc2/chapter2-chapitre2/#ch2_en_a2.2
Back to top
PreviousNext
Posted November 29, 2019.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Obstetrical safety indicators for preventing hospital harms: a scoping review protocol
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Obstetrical safety indicators for preventing hospital harms: a scoping review protocol
A Conway, J Reszel, MC Walker, JM Grimshaw, SI Dunn
medRxiv 19012153; doi: https://doi.org/10.1101/19012153
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Obstetrical safety indicators for preventing hospital harms: a scoping review protocol
A Conway, J Reszel, MC Walker, JM Grimshaw, SI Dunn
medRxiv 19012153; doi: https://doi.org/10.1101/19012153

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Obstetrics and Gynecology
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1240)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10023)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2281)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4834)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)